PDCD4 and bone neoplasm: miR-208a: Fa et al., displayed that miR-208a increases the viability, migration, and clonogenicity of osteosarcoma cells via downregulation of PDCD4 and activation of the ERK1/2 pathway, highlighting its key role in bone tumor pathogenesis [73].